Truepoint, Inc. Abb Vie Inc. Transaction History

Truepoint, Inc.

$3.65 Billion
Q3 2024

A detailed history of Truepoint, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Truepoint, Inc. holds 2,256 shares of ABBV stock, worth $382,685. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,256

Previous 1,683 34.05%

Holding current value

$382,685

Previous $288,000 54.51%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $93,880 - $114,216	573 Added 34.05%	2,256 $445,000
Q2 2024 Aug 05, 2024	SELL	$154.79 - $180.76 $10,525 - $12,291	-68 Reduced 3.88%	1,683 $288,000
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $566,881 - $645,908	-3,547 Reduced 66.95%	1,751 $318,000
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $111,593 - $125,680	-811 Reduced 13.28%	5,298 $821,000
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $451,801 - $523,026	3,382 Added 124.02%	6,109 $910,000
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $124,294 - $154,676	938 Added 52.43%	2,727 $367,000
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $58,856 - $67,781	407 Added 29.45%	1,789 $285,000
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $140,661 - $168,689	-1,017 Reduced 42.39%	1,382 $223,000
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $137,620 - $174,960	1,000 Added 71.48%	2,399 $367,000
Q1 2022 May 11, 2022	BUY	$131.98 - $163.75 $184,640 - $229,086	1,399 New	1,399 $227,000
Q4 2021 Feb 02, 2022	SELL	$107.43 - $135.93 $698,187 - $883,409	-6,499 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $501,569 - $569,356	4,714 Added 264.09%	6,499 $701,000
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $187,799 - $209,219	1,785 New	1,785 $201,000
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $156,606 - $237,434	-2,428 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $175,131 - $219,127	2,428 New	2,428 $215,000
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $163,987 - $209,614	-2,496 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $192,541 - $226,611	2,496 New	2,496 $201,000

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truepoint, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Truepoint, Inc. with notifications on news.

Account